A mutation in the V1 end domain of keratin 1 in non-epidermolytic palmar-plantar keratoderma.

Mutations in keratin 9 have been found in families with an epidermolytic form of palmar-plantar keratoderma (PPK). In another form of PPK (Unna-Thost type), epidermolysis is not observed histologically. We studied a pedigree with this non-epidermolytic form of PPK. By gene linkage analysis, the type I keratin locus could be excluded but complete linkage with the type II keratin region was found. Sequence analysis identified a single base change in the amino-terminal V1 variable subdomain of keratin 1, which caused a lysine to isoleucine substitution. This non-conservative mutation completely cosegregated with the disease and was not observed in 50 unrelated unaffected individuals. An examination of keratin amino-terminal sequences revealed a previously unreported 22-residue window in the V1 subdomain that is conserved among most type II keratins. The altered lysine is an invariant residue in this conserved sequence. Previously described keratin mutations affect the central regions important for filament assembly and stability, and cause diseases characterized by cellular degeneration or disruption. This is the first disease mutation in a keratin chain variable end region. The observation that it is not associated with epidermolysis supports the concept that the amino-terminal domain of keratins may be involved in supramolecular interactions of keratin filaments rather than stability. Therefore, hyperkeratosis associated with this mutation may be due to perturbations in the interactions of the keratin end domain with other cellular components.

[1]  E. Fuchs,et al.  Intermediate filaments and disease: mutations that cripple cell strength , 1994, The Journal of cell biology.

[2]  S. Bale,et al.  Preferential sites in keratin 10 that are mutated in epidermolytic hyperkeratosis. , 1994, American journal of human genetics.

[3]  Karl Sperling,et al.  Keratin 9 gene mutations in epidermolytic palmoplantar keratoderma (EPPK) , 1994, Nature Genetics.

[4]  S. Bale,et al.  Mutations in the H1 and 1A domains in the keratin 1 gene in epidermolytic hyperkeratosis. , 1994, The Journal of investigative dermatology.

[5]  E. Lane,et al.  Mutations in the rod 1A domain of keratins 1 and 10 in bullous congenital ichthyosiform erythroderma (BCIE). , 1994, The Journal of investigative dermatology.

[6]  J. Compton.  Epidermal disease: faulty keratin filaments take their toll , 1994, Nature Genetics.

[7]  G. Lenoir,et al.  Epidermolytic palmoplantar keratoderma cosegregates with a keratin 9 mutation in a pedigree with breast and ovarian cancer , 1994, Nature Genetics.

[8]  S. Bale,et al.  Concurrence between the molecular overlap regions in keratin intermediate filaments and the locations of keratin mutations in genodermatoses. , 1993, Biochemical and biophysical research communications.

[9]  A. Letai,et al.  Disease severity correlates with position of keratin point mutations in patients with epidermolysis bullosa simplex. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[10]  D. Parry,et al.  The conserved H1 domain of the type II keratin 1 chain plays an essential role in the alignment of nearest neighbor molecules in mouse and human keratin 1/keratin 10 intermediate filaments at the two- to four-molecule level of structure. , 1993, The Journal of biological chemistry.

[11]  P. Steinert,et al.  The two size alleles of human keratin 1 are due to a deletion in the glycine-rich carboxyl-terminal V2 subdomain. , 1992, The Journal of investigative dermatology.

[12]  G. Gyapay,et al.  A second-generation linkage map of the human genome , 1992, Nature.

[13]  E. Fuchs,et al.  The roles of K5 and K14 head, tail, and R/K L L E G E domains in keratin filament assembly in vitro , 1992, The Journal of cell biology.

[14]  Elaine Fuchs,et al.  The genetic basis of epidermolytic hyperkeratosis: A disorder of differentiation-specific epidermal keratin genes , 1992, Cell.

[15]  S. Bale,et al.  A leucine→proline mutation in the H1 subdomain of keratin 1 causes epidermolytic hyperkeratosis , 1992, Cell.

[16]  S. Kubicka,et al.  Characterization of human cytokeratin 2, an epidermal cytoskeletal protein synthesized late during differentiation. , 1992, Experimental cell research.

[17]  D Hohl,et al.  Mutations in the Rod Domains of Keratins 1 and 10 in Epidermolytic Hyperkeratosis , 1992, Science.

[18]  C. Amos,et al.  Linkage of epidermolytic hyperkeratosis to the type II keratin gene cluster on chromosome 12q , 1992, Nature Genetics.

[19]  J. Weber,et al.  Closing in on a breast cancer gene on chromosome 17q. , 1992, American journal of human genetics.

[20]  O. Mcbride,et al.  Extensive size polymorphism of the human keratin 10 chain resides in the C-terminal V2 subdomain due to variable numbers and sizes of glycine loops. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[21]  C. Bottema,et al.  PCR amplification of specific alleles (PASA) is a general method for rapidly detecting known single-base changes. , 1992, BioTechniques.

[22]  R. Rice,et al.  Transglutaminases: multifunctional cross‐linking enzymes that stabilize tissues , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  Elaine Fuchs,et al.  Point mutations in human keratin 14 genes of epidermolysis bullosa simplex patients: Genetic and functional analyses , 1991, Cell.

[24]  A. Steven,et al.  Glycine loops in proteins: their occurrence in certain intermediate filament chains, loricrins and single-stranded RNA binding proteins. , 1991, International journal of biological macromolecules.

[25]  E. Lane,et al.  Retrovirus-mediated transgenic keratin expression in cultured fibroblasts: Specific domain functions in keratin stabilization and filament formation , 1990, Cell.

[26]  D. Parry.  Primary and Secondary Structure of IF Protein Chains and Modes of Molecular Aggregation , 1990 .

[27]  P. Steinert,et al.  The dynamic phosphorylation of the human intermediate filament keratin 1 chain. , 1988, The Journal of biological chemistry.

[28]  D. Parry,et al.  Intermediate filament structure: 3. Analysis of sequence homologies , 1988 .

[29]  R. Moll,et al.  Distribution of a special subset of keratinocytes characterized by the expression of cytokeratin 9 in adult and fetal human epidermis of various body sites. , 1987, Differentiation; research in biological diversity.

[30]  J. Ott.  Analysis of Human Genetic Linkage , 1985 .

[31]  R. Mcconnell,et al.  Carcinoma of the oesophagus with keratosis palmaris et plantaris (tylosis): a study of two families. , 1958, The Quarterly journal of medicine.